CClinicalTrials.gg
CompletedNCT00723996Updated Dec 16, 2016

Preventive Health Behavior in Women

An observational study in Colon Cancer, sponsored by University of Michigan. Completed at 1 site in United States. Open to female participants aged 50 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-12-16.

Sponsored by University of Michigan · Observational

Study type
Observational
Time perspective
Prospective
Enrollment
254
Ages
50 Years to 75 Years
Sex
Female
01

Study summary

The overall goal of the proposed research is to explore behavioral correlations between colorectal cancer screening and screening mammography.

Read the detailed description

The overall goal of the proposed research is to explore behavioral correlations between colorectal cancer screening and screening mammography and to develop an innovative approach for reducing barriers colorectal cancer screening in women, using screening mammography, an existing non-colon cancer related screening test that has widespread public acceptance, as a "teachable moment." Although screening for colorectal cancer (CRC) has been shown to decrease the incidence of CRC and CRC associated mortality, adherence to screening guidelines from the American Cancer Society and the American Gastroenterological Association remains poor.1-5 Barriers to adherence are not fully defined, but may include poor understanding of the relative benefits and risks of CRC screening, absence of physician recommendation, lack of insurance coverage for screening procedures, and poor patient acceptance of screening procedures. A potential challenge in increasing patient knowledge may be the milieu in which the educational intervention is administered. This study will be the first prospective study to evaluate the effectiveness of an educational intervention designed to increase CRC screening administered at a cancer screening visit unrelated to CRC.

02

Conditions studied

  • Colon Cancer

Browse trials for

03

In context

Colonic Neoplasms

1,433 studies on the registry are indexed under Colonic Neoplasms; 358 are open to participants now.

This study's enrollment of 254 is close to the median of 280 across 350 observational studies indexed under Colonic Neoplasms.

Browse Colonic Neoplasms studies →

Lead sponsor

University of Michigan is the lead sponsor of 1,476 studies on the registry; 197 are open to participants now.

Of its 162 completed or terminated interventional studies of FDA-regulated products, 128 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 75 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Women who are scheduled for a screening mammogram at a University Medical Center who are between 50 and 75 years old will recruited.

Inclusion criteria

  1. Women between the ages of 50 and 75 years old.
  2. Scheduled for a screening mammogram.

Exclusion criteria

Exclusion Criteria:

  1. CRC screening current (FOBT within preceding 12 months, FS within 5 years, or colonoscopy within 10 years).
  2. Family history of CRC in a first-degree relative.
  3. Personal history of colonic adenomatous polyps, CRC or inflammatory bowel disease
05

Study design

Time perspective
Prospective
Enrollment
254 participants (actual)

Groups and cohorts

  • Group 1

    Women receiving a CRC-related questionnaire and a CRC educational video.

    Behavioral: Behavioral Study in Women

  • Group 2

    Women who receive only a CRC-related questionnaire.

  • Group 3

    Women who receive neither questionnaire nor educational video.

    Behavioral: Behavioral Study in Women

Interventions

  • BehavioralBehavioral Study in Women

    A Randomized study to assess the knowledge of womens health related issues

06

What researchers measure

Primary outcomes

  1. The primary outcome will be determined through review of medical records or a telephone follow-up 6 months after enrollment

    Time frame: At 6 month intervals

07

Study locations

1 site
  • University of Michigan Health System
    Ann Arbor, Michigan 48109, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 16, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00723996
Lead sponsor
University of Michigan
Responsible party
Ruth Carlos M.D. (Principal Investigator, University of Michigan) — Principal investigator
First posted
Jul 29, 2008
Start date
Sep 2003
Primary completion
Sep 2016
Completion
Sep 2016
Last update
Dec 16, 2016

Study contacts

Ruth Carlos, MD
principal investigator · University of Michigan

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion